Table 1.
Patient Clinicopathological Characteristics and Obstetric Outcomes
| Clinical Characteristics | No. of Patients (%) |
|---|---|
| Age (years) | |
| ≥30 | 4 (28.6) |
| ≥20 and <30 | 9 (64.3) |
| <20 | 1 (7.1) |
| Parity (n) | |
| 0 | 12 (85.7) |
| 1 | 2 (14.3) |
| Gestation age of diagnosis | |
| 1st Trimester | 10 (71.4) |
| 2nd Trimester | 3 (21.4) |
| 3rd Trimester | 1 (7.1) |
| Histological subtypes | |
| Dysgerminoma | 1 (7.1) |
| Immature teratoma | 4 (28.6) |
| Yolk sac tumor | 6 (42.9) |
| Mixed germ cell tumors | 3 (21.4) |
| Extent of disease | |
| Localized | 11 (78.6) |
| Metastatic | 3 (21.4) |
| Tumor rupture | |
| Yes | 8 (57.1) |
| No | 6 (42.9) |
| Lymph node metastasis | |
| Yes | 1 (7.1) |
| No | 13 (92.9) |
| Pregnancy outcome | |
| Live birth | 7 (50.0) |
| Premature death | 1 (7.1) |
| Elective abortiona | 6 (42.9) |
| Gestation age of delivery | |
| Full-term | 4 (50.0) |
| Pre-term | 4 (50.0) |
Note: aTwo patients selected termination after one cycle of postoperative chemotherapy.
Abbreviation: MOGCTs, malignant germ cell tumors.